Running Point Capital Advisors, LLC Abbott Laboratories Transaction History
Running Point Capital Advisors, LLC
- $290 Million
- Q4 2024
A detailed history of Running Point Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Running Point Capital Advisors, LLC holds 3,200 shares of ABT stock, worth $431,839. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,200
Previous 3,222
0.68%
Holding current value
$431,839
Previous $367,000
1.63%
% of portfolio
0.12%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,362Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.8 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.4 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.17 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.3 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...